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Abstract 
The influence of bradykinin on submaxillary saliva was investigated 
in an attempt to elucidate the pathogenesis of cystic fibrosis,, Using 
contralateral glands as controls, submaxillary glands of cats were perfused 
with synthetic bradykinin of a concentration in excess of that found in 
human plasma. Patterns of flow rate, concentrations and excretions of 
calcium, sodium, potassium and chloride were determined. These 
patterns exhibited no resemblance to those found in patients with cystic 
fibrosis. The results of this investigation appear to indicate that the 
clue to the pathogenesis of cystic fibrosis does not lie in the kallikrein- 
kinin system. Alternate theories of the basic defect in cystic fibrosis 
are discussed and the direction of further investigation is indicated. 
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The influence of bradykinin on submaxillary saliva was investigated 
in an attempt to elucidate the pathogenesis of cystic fibrosis (C. F,). 
C. F0 is an inherited disorder that affects many and perhaps all exocrine 
1 
glands . Well defined abnormalities have been observed in both sweat 
2 
and saliva, as well as in pancreatic secretions . The kallikrein kinin 
system is thought to be involved in the normal function of these exocrine 
3 
glands. Fox and Hilton have demonstrated that vasodilatation occurring 
in the human forearm on indirect heating has several features in common 
with salivary gland vasodilatation, and that sweat gland activity leads to 
the appearance of kallikrein in the sweat and to the formation of bradykinin 
in the skin. Bradykinin production has been demonstrated in the active 
4 
pancreas , and this vasoactive peptide is released in shock-producing 
5 
quantities in acute experimental pancreatitis . Electron microscopic and 
histochemical localization studies in guinea pigs and cats have demonstrated 
electron dense and PAS-positive kallikrein-containing granules in both the 
6-8 
pancreas and submaxillary glands 
There is some controversy regarding the role of the kinin system in 
the normal function of the salivary glands. Salivary kallikrein was first 
9 
described in 1936 by Werle and Roden , and during the same year, Ungar 
10 
and Parrot suggested that salivary kallikrein is released during salivary 
secretion and that it is the mediator of the atropine-resistant vasodilatation 
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11-13 
is supported by the work of Hilton and Lewis , who showed that 
kallikrein was released from the submaxillary gland of the cat after 
stimulation of the chorda nerve, and that this release was not affected 
by administration of atropinec 
14-19 
Criticism of this theory has arisen from recent studies 
16 
Bhoola et al have shown that in a submaxillary gland perfused with a 
kininogen-free fluid, maximal vasodilatation can be achieved by chorda 
18 
stimulation. Skinner and Webster demonstrated that perfusion of the 
cat's submaxillary gland with carboxypeptidase B, a kininase, completely 
blocked the vasodilatation produced by bradykinin infusion but had no effect 
19 
on vasodilatation produced by chorda stimulation. Beilenson et al found 
that sympathetic stimulation produces a higher concentration and output of 
kallikrein from the submaxillary gland than does parasympathetic stimula¬ 
tion. They also found that glands depleted of kallikrein responded to chorda 
stimulation with normal, atropine resistant vasodilatation, and thus suggested 
that the kallikrein-kinin system does not play a significant role in submaxillary 
gland vasodilatation. 
More recent studies lend support to the theory of kinin-mediated vaso- 
5 
dilatation in exocrine glands. Popieraitis and Thompson demonstrated that 
intra-arterial infusion of bradykinin led to an increase in both the volume 
20 
and blood content of the pancreas. Gautvik et al have shown that the 
level of kininogenase in the venous effluent of the cat's submaxillary gland 
decreases when the gland is activated either by chorda nerve or acetycholine 
stimulation and that this increase is not affected by atropine. Further 
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21 
studies by Gautvik indicated the presence of two vasodilator mechanisms 
in the submaxillary gland. The first is a rapid vasodilatation induced by 
chorda stimulation. The second, later phase of vasodilatation strongly 
suggests the formation of kinins secondary to activation of the gland. 
Despite existing controversy, the kinin system appears to play some role, 
although not well-defined, in normal salivary gland function. 
The role of any specific substance, however, in the pathogenesis of 
22 
cystic fibrosis is quite unclear. Observations made by Spock et al 
indicate that there is an abnormal serum factor in patients with C. F. 
which is not present in normal children and is present in small concentra¬ 
tions in parents of children with C. F. This factor causes an asymmetrical 
ciliary beat in explanted human and animal respiratory-tract epithelium. 
23 
It has also been found to inhibit ciliary motion in oysters . The factor 
is present in the euglobulin fraction of serum, and activity has been 
22 24 
demonstrated in the 19S macroglobulins . Haverback et al have isolated 
a 19S macroglobulin in plasma which binds trypsin in a manner which pro¬ 
tects its esterolytic activities from inhibition, and have shown that a 
mechanism exists in plasma for the binding or conjugation of kallikreins 
to this macroglobulin. They have also shown that the amount of trypsin 
that can be bound by serum of C„ F. patients was twice that of control 
hospitalized patients. Using a modified Schultz-Dale assay apparatus, 
25 
Lieberman and Littenberg showed that saliva from patients with C. F, 
had a significantly greater kallikrein content than saliva from controls. 
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4 
We therefore originated the hypothesis that the serum factor in cystic 
fibrosis is responsible for binding and protecting kallikrein and that this 
excess available kallikrein produces excess amounts of bradykinin in 
exocrine glands. A problem arose concerning the best method to test 
this hypothesis. Direct infusion of serum of C. F. patients into an animal 
could not be undertaken because kallikreins of one species are notably 
16, 26 
ineffective in releasing kinins in different species 
Submaxillary glands of patients with C. F secrete saliva with different 
electrolyte concentrations and at different flow rates than those found in 
27 
normal children. Mandel et al have shown that C. F, submaxillary 
saliva contains significantly higher concentrations of calcium, sodium 
and chloride, higher potassium concentrations and lower flow rates than 
28, 29 
saliva from normal children. Other investigators have been able to 
demonstrate significant elevations only of calcium in C.F. submaxillary 
35 
saliva. Although serum calcium concentrations are normal , elevations 
30, 31 
of calcium concentration have also been found in parotid saliva , 
32 33 34 35 
sweat , tracheobronchial secretions , meconium and duodenal fluid 
of patients with C.F. 
The half life of synthetic bradykinin in blood is 17 seconds and brady- 
36 
kinin is inactivated in the lung „ This investigation was therefore designed 
to use one submaxillary gland of the cat as a control, and to-perfuse the 
other submaxillary gland with synthetic bradykinin in an attempt to show 
a significant elevation of salivary calcium concentrations and to reproduce 
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Materials and Methods 
Mature cats weighing between 2. 3 kg and 4. 3 kg were anesthetized 
with intravenous Nembutal (10 mg/kg)„ An intravenous catheter was 
placed in the left fore leg using a polyethelene tube (PE 50) through 
which maintenence fluids (5% dextrose in 1/2 normal saline) were 
delivered at a rate of 0. 144 ml/kg/min by means of a constant in¬ 
fusion pump, and through which Nembutal was administered as necessary 
to maintain surgical levels of anesthesia. A midline incision was made 
in the neck, through which a tracheotomy was performed and a tracheos¬ 
tomy tube inserted. The right common carotid artery was then isolated 
and cannulated with polyethelene tubing (PE 10) through which fluids were 
delivered at a rate of 0. 057 ml/kg/min by means of a constant infusion pump. 
This catheter offered little obstruction to arterial flow. The mouth was then 
held open and the papillae containing the terminal arborizations of both left 
and right submaxillary ducts were excised, thus exposing the main sub¬ 
maxillary ducts. These ducts were cannulated with the attenuated ends of 
equal lengths of polyethelene tubing (PE 90). Pilocarpine was infused at 
a constant rate of 5.76 mg/kg/min through the intravenous fore leg catheter. 
After free flow of saliva was established for 30 minutes and a steady 
state achieved, collection of saliva into tared vials was begun. Collection 
periods were 5 minutes each and were grouped into 3 longer periods of 
30 minutes each. During the first 30 minute period, hereafter referred 
to as T^ for the cannulated test side and for the control side, normal 
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6 
saline was infused into the cannulated common carotid artery. During the 
second 30 minute period (C£ and T^), synthetic bradykinin (Sandoz) was 
infused at a constant rate of 0.456 pg/kg/min into the cannulated artery. 
During the third 30 minute period (C3 and T^), normal saline was infused 
into the cannulated carotid. The arterial supply to the contralateral sub¬ 
maxillary gland was unaltered, and saliva from that gland served as a 
control. 
Vials were re-weighed immediately after collection and, assuming a 
specific gravity of 1. 000 for saliva, flow rates were calculated. Each 
sample was then diluted with 5 ml. distilled water and analyses of calcium, 
sodium, potassium and chloride were performed. Calcium concentrations 
were determined using a Perkin-Elmer Atomic Absorption Spectrophoto¬ 
meter Model 303 with distilled water as a blank. Chloride analyses were 
performed on a Cotlove chloridometer, and sodium and potassium deter¬ 
minations were made with a flame photometer against a lithium blank. 
Duplicate analyses were performed which correlated closely with each other. 

7 
Res ult s 
Experiments were conducted on 15 animals and the results obtained 
from 7 of those animals are presented here. Reasons for the inability 
to include results from the remaining 8 animals are as follows: anesthetic 
death (2 animals), inability to cannulate submaxillary ducts (2 animals), 
intermittent blockage of submaxillary ducts (3 animals) and blockage of 
carotid artery cannula (1 animal). 
Parameters measured in these experiments were salivary flow rates, 
concentrations of calcium, sodium, potassium and chloride, and excretion 
rates of these electrolytes. Results from each 5 minute sample were av¬ 
eraged to obtain mean values for C^, C^j T|, T^, and for each 
animal. These values were grouped, a mean for all cats obtained and 
standard deviations calculated. Results are presented in figs 1-9 and 
tables 1-3. Changes in all parameters (C^-C^), (C^-£>2)* (T2~T^) an<^ 
(T^-T^) were calculated for each animal. These values were grouped, a 
mean for all cats obtained and standard deviations calculated. Results are 
presented in tables 4-6. Although the data presented indicate trends of 
increasing or decreasing mean values, not all animals followed the trend 
for a given parameter. 
The effects of bradykinin infusion were interpreted as the mean change 
of test parameters from steady state levels, compared to the mean change 
of control parameters during the same collection periods (T^-T^) - (C^-C^) 
Likewise, the effects of cessation of bradykinin infusion were interpreted 

8 
as the mean change of parameters from levels during bradykinin infusion 
compared to the mean change of control parameters during the same 
collection periods (T^-T^) - (C^-C-^) . The degree of statistical signi¬ 
ficance of test changes compared to control changes was determined by the 
Students "T" test. 
Salivary flow rates (fig. 1, table 1) of control glands showed a gradual 
decrease over the total collection time from a mean steady state rate of 
0.243 ml/min to a mean rate of 0.195 ml/min. Test glands showed a de¬ 
crease in flow rate from 0.218 ml/min to 0. 208 ml/min with infusion of 
bradykinin, and a further decrease from 0.208 ml/min to 0. 188 ml/min 
with cessation of bradykinin infusion. During infusion of bradykinin there 
was a decrease in flow rate of 0.004 ml/min (table 4) greater than the 
decrease in controls (p>0.50). Flow rate of experimental saliva after 
cessation of bradykinin infusion decreased by 0. 014 ml/min less than the 
decrease in control rate during the same collection period (p>0.50). 
Mean calcium concentrations (fig, 2,table 2 ) of control saliva showed 
an initial increase from 1. 10 mEq/L to 1.49 mEq/L, followed by a slight 
decrease to 1.43 mEq/L. Experimental saliva showed an increase from 
a mean steady state calcium concentration of 0.86 mEq/L to 1.06 mEq/L 
with infusion of bradykinin, followed by a further increase to a mean concen¬ 
tration of 1.62 mEq/L after cessation of bradykinin infusion. During infusion 
of bradykinin there was an increase in calcium concentration of 0. 19 mEq/L 
less than the increase in control saliva (p>. 50) (table 5). Calcium concen¬ 
tration of experimental saliva after cessation of bradykinin increased by 
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9 
0. 62 mEq/L compared to the change in control calcium concentration 
during the same collection period (p >. 10). Neither of these increases 
were statistically significant. Patterns of control and experimental rates 
of calcium excretion were similar to each other (fig. 3, table 3) with an 
initial increase in excretion rate followed by a slight decrease. Mean 
changes were insignificant (table 6), showing that during infusion of brady- 
kinin there was an increase in calcium excretion of 0. 017 pEq/min greater 
than the increase seen in control saliva (p >. 50). Calcium excretion of 
experimental saliva after cessation of bradykinin infusion decreased by 
0.018 [iEq/min less than the decrease in control calcium excretion during 
the same collection period (p > . 40). 
The pattern of sodium concentration and excretion in experimental 
saliva was not significantly different from that of control saliva. Sodium 
concentrations of both control and experimental saliva showed a steady but 
insignificant increase over the entire collection period (fig. 4, table 2) 
from 33.2 mEq/L to 67.7 mEq/L in controls, and from 20.2 mEq/L to 
42.4 mEq/L in experimental saliva. During infusion of bradykinin there 
was mean increase of 9. 5 mEq/L less in experimental saliva than the increase 
seen in control saliva (p > 0.50) (table 5). Sodium excretions (fig. 5, table 3) 
of both control and experimental saliva also showed a steady increase over 
the whole collection period from 4. 55 pEq/min to 8. 47 pEq/min in controls 
and from 4.07 |fEq/min to 7.32 pEq/min in experimental saliva. During 
infusion of bradykinin there was a mean increase of 0.94 pEq/min less in 
experimental saliva than the increase seen in control saliva (p >0. 50), and 
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10 
after cessation of bradykinin infusion there was an increase of 0.29 Eq/min 
more in experimental saliva than the increase seen in control saliva (p>0. 50) 
(table 6)„ 
Potassium concentrations (fig 6, table 2) in control saliva rose from 
9.6 mEq/L to 12.9 mEq/L over the entire collection period, whereas 
experimental salivary concentrations rose from 10. 1 mEq/L to 11.0 mEq/L 
during the infusion of bradykinin and then fell to 10.6 mEq/L after cessation 
of bradykinin infusion. The decrease in potassium concentration after 
cessation of bradykinin infusion is more apparent than real since there is 
considerable overlap of individual control and experimental values. During 
the infusion of bradykinin there was an increase of 0.6 mEq/L less in 
experimental saliva than the increase observed in control saliva (p>0. 20). 
Potassium concentration of experimental saliva after cessation of bradykinin 
infusion decreased by 2.2 mEq/L compared to the change in control potassium 
concentration during the same collection period (p>0„ 05) (table 5). 
Potassium excretions (fig. 7, table 3) exhibited a small but insignificant 
increase from 1.84 n Eq/min to 1.94 M-Eq/min in control saliva followed by 
a decrease to 1.81 PEq/min, and showed a decrease from 2.40 MEq/min to 
1 
2. 30 fjEq/min in experimental saliva with infusion of bradykinin, followed by 
a further decrease to 2. 10 pEq/min in experimental saliva after cessation of 
bradykinin infusion. Bradykinin infusion thus was accompanied by a mean 
decrease in potassium excretion of 0. 20 pEq/min compared to the change in 
control saliva during the same collection period (p>0o30). Potassium excretion 
of experimental saliva after cessation of bradykinin infusion decreased by 
[■ -.W . 
.'■a .: 
< oi : or . jo 
"o: ; -.s c 
i'. -• O \ O 
\ 7 . ' of- \. O': -• o . . oi - v-~r o' " i.? j ~. 
- t \r s ' i ■ i - o . ci ::i : 
. o/;- . r •- r o .ro ■' .. -ii n j _o , c 
O . ’ OJT: '. O ci 
- O • o J S'.' j J *. J O v • O 1 o, > J .• Q3 
i- c - i o .or ., ' j- - 
- O- or • j : - • «>o ■■■ooio i sj " _ . 
x • : .s " ■ o oi ’O Oj~ o roc • j ' . r r'' 
•' I •. ■ n J n or C*X t; o.' '■ - •. 'or j \ oj.. 
( \ 
ci" ' . oi -rrjjo: -ir . ci" •. r or- 




t‘ i X " - ' O :ci 
‘ r- O' 
r , 
o. - j5 :z s 
i A. ■ 
O - O /- . • • 
O r .0 0."'? 
rr. 'C OI i J oilXi - 
: i 
r.p/ o 
0 X \ - O OJ 
Cj . 01 J I 
’ i • r - o i 
or . . i • .. 
oi rr ~c. -roj. or : A' I . i J . o ' c: 
o oi s ■ ^ r 
11 
O0 07 MEq/min more than the decrease seen in control saliva during the 
same collection period (p>0o 50) (table 6), Neither of these decreases 
are significant. 
Chloride concentration (fig. 8, table 2) in control saliva showed a 
rise from 6. 75 mEq/L to 9. 78 mEq/L, which was paralleled by a rise 
from 7.79 mEq/L to 10.9 mEq/L in experimental saliva with infusion 
of bradykinin. Control chloride concentrations then decreased slightly 
to 9.23 mEq/L but experimental concentrations continued to rise to 
17. 1 mEq/L after cessation of bradykinin infusion. Infusion of brady¬ 
kinin was thus associated with an insignificant (p>0»50) mean increase 
in chloride concentration of 0.08 mEq/L greater than the rise in control 
values. Chloride concentration of experimental saliva after cessation 
of bradykinin infusion increased by 6.75 mEq/L compared to the change in 
control values during the same collection period (table 5). The latter in¬ 
crease,although large, is statistically insignificant (p> 0. 10). Chloride 
excretions (fig. 9, table 3) of control saliva showed a steady decrease over 
the entire collection period from 1. 84 MEq/min to 1.49 M-Eq/min. Experi¬ 
mental values increased from 2. 37 pEq/min to 3. 22 pEq/min with infusion 
of bradykinin and continued to rise to 3. 39 M-Eq/min after cessation of 
bradykinin infusion. During infusion of bradykinin there was an increase in 
chloride excretion of 0.91 MEq/min compared to the change in control saliva 
(p>0.20) chloride excretion after cessation of bradykinin infusion increased 
by 0.46 pEq/min compared to the change in control chloride excretion during 
the same collection period (p>0. 50) (table 6). 
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Mean Salivary Flow Rates 
Mean S. D. Mean S. D„ 
C1 
0o 243 0o 148 
Ti 
0.218 0. 021 
C2 
0. 229 0, 174 
T2 
0. 208 0. 093 
C3 
0. 195 0. 138 
T3 
0. 188 0. 097 
values are expressed in ml/min 
Table 2 
Mean Electrolyte Concentrations 
Mean S0 D. Mean So Do 
Ca 
ci 
1. 10 0. 66 
T1 




1.06 0o 57 
C3 1.43 0. 69 T3 
1.62 0. 83 
Na 
ci 33. 2 44. 1 T1 20. 2 18 o 1 
C2 55. 4 46 o 6 T2 32. 8 16o 7 
C3 67. 7 52o 5 T3 42. 4 17o 3 
K 
ci 9. 6 3. 1 Tl 10o 1 lo 1 
C2 11. 1 4. 2 T2 11.0 2. 6 
c3 12. 9 5. 7 T3 10o 6 1 o 9 
Cl 
ci 6. 75 2. 77 Tl 7. 79 6o 62 
C2 9. 78 6o 93 T2 10o 89 lo. 12 
C3 9.. 23 8. 00 T3 17. 10 IQ. 61 





Mean Electrolyte Excretions 
Mean So D. Mean SoD. 
ci 
0o 184 0o 101 
T1 
0o 192 0. 073 
Ca 
C2 
0. 250 0. 206 
T2 
0. 275 0o 164 
C3 0o 226 0. 188 T3 0o 269 0o 150 
ci 4. 57 3o 97 T1 40 07 3. 17 
Na 
C2 
7. 03 6. 94 
T2 
5o 59 3„ 03 
C3 8, 47 7. 60 t3 7„ 32 5o 36 
C1 
1.84 0o 75 
T1 
2. 40 0. 45 
K 
C2 
1.94 0. 98 
T2 
2. 30 1.04 
C3 1.81 1.01 T3 2. 10 0. 24 
C1 
1.84 lo 40 ti 2„ 37 lo 78 
Cl 
C2 
1.78 0. 78 
T2 
3. 22 3. 55 
C3 1.49 I. 08 T3 3.39 3. 39 
values are expressed in iaEq/min 
cj - ' -: j 
23 
Table 4 
Mean Salivary Flow Rate Changes 
C2~C1 T2-Tl C3-C2 T3-T2 
Mean -Oo 014 -Oo 010 -0o 034 -0o 020 
S„ D„ 0. 045 Oo 079 0o 083 0o 048 
values are expressed in ml/min 
Table 5 
Mean Electrolyte Concentration Changes 
C2-°l 
T -T 









 1 + 0o 56 
SoDo lo 00 0o 12 Oo 44 0. 54 
Na 
Mean + 22. 1 + 12. 6 + 1 2„ 4 + 9. 8 
SoDo 10o 1 8. 6 6. 5 18. 3 
K 
Mean + 1.5 + 0o 9 + 1.8 - 0. 4 
SoD. 1. 1 1. 5 1.6 0o 7 
Cl 
Mean + 30 03 + 3. 11 - 0o 55 + 6o 20 
So D. 5„ 91 5o 24 lo 67 9o 59 
values are expressed in mEq/L 
. cl .•? ul> i ,S‘- 





Mean Electrolyte Excretion Changes 
Cl, cz Ti. T2 c2> C3 t2> 
Ca 
Mean + 0. 066 + 0.083 - 0.024 - 0.006 
S. D. 0. 163 0. 108 0. 037 0. 056 
Na 
Mean + 2. 46 + 1. 52 + 1.44 + 1.73 
S0 D. 3. 44 1. 76 2. 09 4. 28 
K Mean 
+ 0. 10 - 0. 10 - 0. 13 - 0.20 
S„ D. 0. 25 0. 85 0. 09 0,89 
Cl Mean 






S„ D. 0. 79 2. 44 0. 97 1.98 
values are expressed inpEq/min 
oh ' 
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Dis cus sion 
It was thought that if exocrine glands in patients with C. F» were 
chronically exposed to high concentrations of bradykinin, an attempt 
to duplicate this situation in an acute experiment could be made by using 
37 
very high local concentrations of bradykinin. Borcklehurst and Zeitlin 
have determined that the free plasma kinin level in man is 2.8 ng/ml. 
Based on an estimate of unilateral carotid blood flow (7. 5% of cardiac 
output) and an estimated cardiac output (71 ml/min/kg) coupled with the 
known concentration and rate of infusion of the synthetic bradykinin, the 
calculated concentration of bradykinin in the plasma flowing through the 
experimental carotid artery was approximately 0. llOgg/ml. This concen¬ 
tration was decided upon after preliminary experiments using 2. 5% and 
25% of this concentration failed to yield positive results. Neither the 
infusion of this large excess (0. 110 |jg/ml) of bradykinin nor the cessation 
of infusion resulted in any significant difference in the pattern of flow rate, 
electrolyte concentrations or excretions when compared to control patterns 
of these parameters. 
There is a possibility, with such a large dose, that not all of the in¬ 
fused bradykinin was inactivated in the lungs and that some bradykinin 
reached the control gland. If this were indeed the case, one would expect 
any effects of bradykinin to occur in both glands. These effects would be 
observable as a significant change in parameters from values in collection 
period 1 to higher or lower values in collection period 2. P values for any 
changes occurring in either gland between these two collection periods 

26 
were all greater than 0.20„ Thus, even if bradykinin did reach the 
control gland, it did not result in a significant change in any of the para¬ 
meters measured. 
Both control and experimental electrolyte concentrations increased 
steadily with time in the presence of a steadily decreasing flow rate. 
38,39 
These observations agree with those of some investigators but dis- 
40, 41 38 39 
agree with those of others . Both Dreisbach and Neilsen have 
demonstrated an inverse relationship between calcium concentration and 
flow rate in submaxillary saliva after pilocarpine stimulation. Young and 
40 41 
Schogel and Petersen and Poulsen , however, have shown increases in 
sodium and potassium concentrations with an increase in flow rate. A 
possible explanation for our observations is that dehydration may have 
occurred in our animals secondary to constant pilocarpine infusion. 
Another interesting observation is that infusion of bradykinin did not 
increase salivary flow rates. If kinin formation is truly responsible for 
a significant degree of vasodilatation in the salivary gland, one would 
expect an increase in flow rate to occur with infusion of bradykinin. Our 
inability to demonstrate this increase would seem to support the theory of 
7 
Heap and Bhoola who suggest that the PAS-positive kallikrein-containing 
granules present in the submaxillary glands are secreted into the acinar 
or duct lumen rather than into the extracellular tissue space, thus indi¬ 
cating that kallikrein performs an exocrine rather than a local endocrine 
role in the submaxillary gland. 
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The large standard deviations and considerable overlap of control and 
experimental values in this investigation do not allow one to speculate 
further on possible causes of the observed changes because these changes 
may be more apparent than real. 
Although the kallikrein-kinin system has been implicated in many 
disease processes, including pancreatitis, asthma, thermal edema, dump¬ 
ing syndrome, migraine, arthritides, and shock reactions, it has been shown 
to be significantly involved only in carcinoid syndrome and hereditary 
42, 43 
angioedema . The results of this investigation indicate that the local 
infusion of high concentrations of bradykinin does not alter certain para¬ 
meters of submaxillary saliva and does not reproduce the patterns of these 
parameters found in children with cystic fibrosis, thus casting some doubt 
on the role of the kallikrein-kinin system in the pathogenesis of that disease. 
44 
Mangos et al have demonstrated that retrograde perfusion of the ratIs 
parotid gland with saliva from C. F. patients decreased the rate of sodium 
reabsorption, whereas perfusion with saline or normal saliva did not affect 
this rate. They postulate the existance of a sodium transport inhibitory 
45 
factor in the saliva of patients with C.F. Gibson et al , however, feel that 
a defective mucus water barrier is present in C.F. exocrine ducts, thus 
leading to excess passive water reabsorption and resulting in hypertonic and 
viscid exocrine secretions. They have shown that the rate of flow of isotonic 
saline through the non-dialyzable fraction of C.F. submaxillary saliva was 
greater than the rate of flow through similar material from normal children. 
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They have also demonstrated that when calcium is added to normal 
submaxillary saliva, flow rates through the non-dialyzable fraction 
were increased to the levels found in C. F. saliva. 
46 
Gugler et al have investigated the role of calcium in submaxillary 
saliva of C. F0 patients. They have found that normal saliva is clear and 
demonstrates a constant electrophoretic pattern, whereas C. F. saliva is 
turbid and its electrophoretic pattern differs quantitatively though not 
qualitatively from the pattern seen in normal saliva. When a calcium 
chloride solution was added to normal saliva, the saliva became turbid 
and exhibited an electrophoretic pattern similar to that seen in C. F. saliva. 
When EDTA was added to C. F. saliva, the saliva became clear and the 
electrophoretic pattern resembled that seen in normal saliva. They thus 
suggested that the excess calcium in C. F. exocrine secretions forms a 
reversible precipitate with mucus glycoproteins. This precipitate could 
result in the excess water reabsorption postulated by Gibson et al. 
Clarification of these theories awaits further investigation of the ability 
of C. F. serum to produce increased calcium concentrations in exocrine 
secretions. 
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